Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)
Launched by MONTEFIORE MEDICAL CENTER · Dec 13, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called Middle Meningeal Artery Embolization (MMAE) for patients with chronic subdural hematoma, which is a condition where blood collects between the brain and its outer covering. The trial aims to understand how effective this treatment is in real-life situations, how often the condition comes back after treatment, and whether it is safe for patients.
To be eligible for the trial, participants need to be adults aged 18 or older who have undergone MMAE using specific materials like PVA particles or glue. Importantly, the trial is currently recruiting patients of all genders. If someone joins this study, they can expect to have their outcomes monitored to see how well they respond to the treatment over time. Overall, this trial seeks to provide valuable information that could help improve care for patients with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Consecutive adult patients (18 yrs. of age or older)
- * Endovascular embolization of middle meningeal artery using any embolization material:
- • PVA particles; Onyx, nBCA glue; dimethyl sulfoxide, microcoils, PVA with microcoils
- Exclusion Criteria:
- • Endovascular embolization of middle meningeal artery using any other embolization material
About Montefiore Medical Center
Montefiore Medical Center is a leading academic medical institution located in the Bronx, New York, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a principal sponsor of clinical studies, Montefiore fosters a collaborative environment that connects researchers, healthcare professionals, and patients to explore cutting-edge therapies and improve health outcomes. With a strong emphasis on patient-centered care, the center integrates its extensive clinical expertise with robust research capabilities to address a wide range of medical conditions, contributing significantly to the advancement of medical science and clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bronx, New York, United States
Patients applied
Trial Officials
David Altschul, MD
Principal Investigator
Montefiore Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported